story of the week
Outcomes of HER2-Positive Patients With Newly Diagnosed Stage IV or Recurrent Breast Cancer Undergoing First-Line Trastuzumab-Based Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer